• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Orbita Expands COVID-19 Chatbot Screener to Support Front-line Response Demands

Share:

March 31, 2020

Highlights on this story:
  • Orbita expands COVID-19 bot solutions to support new front-line response demands, reaching millions in need.
  • Deployed to your website as a text chatbot, educates patients and screens symptoms seamlessly across web browsers with content from the CDC and other clinically vetted sources.
  • In addition to the screener and knowledge base, the navigator tool directs patients to custom endpoints such as virtual visits, appointment scheduling, a live chat agent, or educational materials.

Orbita today announces the expansion of its COVID-19 chatbot screen and knowledgebase solution offerings to support health systems, hospitals, employers, and government agencies now managing wide-ranging populations with limited resources in response to COVID-19. Using content from trusted sources including the Centers for Disease Control and Prevention (CDC) and Mayo Clinic, Orbita unveiled three new omnichannel solutions: COVID-19 Navigator, COVID-19 Health Check, and COVID-19 Employee Health Check. All provide capabilities for robust screening and knowledge base-driven question-answering. With current customer deployments, Orbita technology is reaching millions.

Expanded COVID-19 Chatbot Solutions

On March 17, 2020, Orbita announced the availability of its no-cost Orbita COVID-19 chatbot with a rich knowledge base designed to deliver COVID-19-specific screening and question-answering.

Orbita has expanded its solutions to include:

Orbita COVID-19 Chatbot Screener and Navigator – To screen patients and direct them to the most relevant services including human agents, virtual visits, online scheduling, and specific patient education materials.

Orbita COVID-19 Health Checker – To support symptomatic and/or at-risk patients through secure assessments that can be delivered proactively through chatbot, text-message or phone calls at regularly scheduled intervals. One Orbita customer is checking in with a target population four times a day.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Orbita COVID-19 Employee Health Checker – For employers to screen, check on, and manage employee populations; to monitor employee health, direct employees to educational and supportive resources, and to provide clearance for work.

Orbita’s COVID-19 Employee Health Check solution is supporting manufacturers and other essential businesses to keep their employees healthy and well-supported as they work around the clock to respond to this crisis. According to Ebong, many large employers are playing a critical role in supplying front-line responders with supplies and equipment. “They’re identifying a need to monitor and manage the health of employees who work both onsite and remotely from home,” she said.

“Our mission around COVID-19 is to reach and help as many people as possible as quickly as possible. Working with our partners, we quickly saw the need to deliver solutions that go beyond the basic web bots that are now proliferating. There’s a true demand for solutions that delivers richer, more relevant experiences to support people across all stages of care and recovery and across all channels — including phone, text message, web, and mobile chatbot,” said Kristi Ebong, MPH, MBA, Orbita SVP of Strategy. “Some of the highest risk populations, especially our aging loved ones, can’t access chatbots. It’s critical that we have a way to check in with them throughout this crisis.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Netflix Documentary Exposes the Dangers of the Medical Device IndustryNetflix Documentary Exposes the Dangers of the Medical Device Industry
  • Medical device startup Kypha raises another $950,000Medical device startup Kypha raises another $950,000
  • 3M to Invest Nearly $150 Million to Advance Capabilities in Biopharma Filtration Technology.3M to Invest Nearly $150 Million to Advance Capabilities in Biopharma Filtration Technology.
  • Novo Nordisk to launch two connected insulin pens, taps Flex to manage dataNovo Nordisk to launch two connected insulin pens, taps Flex to manage data
  • Mesh Bio Bags $3.5M to Bring Digital Twin Tech to Hong Kong, Indonesia, PhilippinesMesh Bio Bags $3.5M to Bring Digital Twin Tech to Hong Kong, Indonesia, Philippines
  • Latest Data for Karuna’s Schizophrenia Drug Spark Investor ConcernLatest Data for Karuna’s Schizophrenia Drug Spark Investor Concern
  • Nektar unveils Inheris Biopharma, its new CNS-focused offshootNektar unveils Inheris Biopharma, its new CNS-focused offshoot
  • VillageMD Becomes Largest Sponsor for CMS New Direct Contracting ProgramVillageMD Becomes Largest Sponsor for CMS New Direct Contracting Program

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications